SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-038716
Filing Date
2023-08-07
Accepted
2023-08-07 06:16:02
Documents
82
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mirm-20230630.htm   iXBRL 10-Q 3822207
2 EX-10.1 mirm-ex10_1.htm EX-10.1 234720
3 EX-31.1 mirm-ex31_1.htm EX-31.1 21313
4 EX-32.1 mirm-ex32_1.htm EX-32.1 12098
  Complete submission text file 0000950170-23-038716.txt   14228368

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mirm-20230630_def.xml EX-101.DEF 341034
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mirm-20230630_pre.xml EX-101.PRE 524698
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mirm-20230630_lab.xml EX-101.LAB 684144
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mirm-20230630.xsd EX-101.SCH 89654
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mirm-20230630_cal.xml EX-101.CAL 69833
76 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20230630_htm.xml XML 2840015
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38981 | Film No.: 231145521
SIC: 2834 Pharmaceutical Preparations